BackDefence Therapeutics Overview

Defence Therapeutics Receivables

Track Defence Therapeutics's receivables ($320K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$315182.00
↑ 259.02% YoYΔ $227393.00 vs prior year quarter

Peer trimmed avg / median

Loading

Defence Therapeutics Receivables History

Loading

Defence Therapeutics vs. peers: Receivables Comparison

Loading

Defence Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Defence Therapeutics (DTCFF) FAQ

As of the most recent data (March 2026), DTCFF shows a receivables of $320K. That compares with $88K in the prior-year period — up 259.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DTCFF's receivables is now $320K (was $88K) — a 259.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Defence Therapeutics is outperforming or lagging.

Tracking DTCFF's receivables over time shows whether Defence Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $320K That compares with $88K in the prior-year period — up 259.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Defence Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $320K) with ownership activity and broader fundamentals.

Defence Therapeutics's receivables is $320K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.